Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA, 19111, USA.
Med Phys. 2019 Apr;46(4):1905-1913. doi: 10.1002/mp.13427. Epub 2019 Feb 20.
The directional planar palladium-103 LDR device (CivaSheet ) may be used for intraoperative implantation at the interface between the tumor site and healthy tissue. Its dosimetric properties have been studied in the ideal case of application on a flat surface. The dosimetric impact of implanting this highly directional device on a curved surface that may be encountered in clinical treatments is analyzed.
CivaSheet is designed as an array of directional palladium-103 sources (CivaDots). From the postoperative computed tomography (CT) scans of three patients, the shape of each implanted CivaSheet was reconstructed. In order to obtain a realistic estimate of the distribution of curvatures, the mean radius of curvature at the location of each CivaDot was calculated. A Monte Carlo simulation (FLUKA) of a single CivaDot was designed, based upon published geometry and material specifications. Both the radial dose function analog and the two-dimensional anisotropy function analog for the CivaDot were validated in comparison with film measurements and benchmarked to published Monte Carlo data. A value for the dose-rate constant Λ = 0.587(19) cGy/h/U for a CivaDot source in water was calculated as well. Knowledge of the dose distribution in the vicinity of each source allowed the dose at any point around CivaSheets of different curvatures and orientations to be calculated.
The local radius of curvature was found to be primarily between 2 and 8 cm in all three patient implants. On the unshielded side of an inward-facing curved CivaSheet implant of radius 2 cm, the calculated dose at 0.5 cm depth exceeded the prescribed dose by ∼20%, while on the shielded side the dose increased by a factor of two, thus compromising the shielding efficiency of the original design. On the unshielded side of an outward-facing curved implant, the dose at 0.5 cm depth decreased by ∼20%.
When tumor bed curvature can be estimated from the preplanning CT scan, the results from this study provide quantitative guide for modifying the source strength to achieve the desired clinical results. In many intraoperative cases, however, accurate preplanning based on surface curvature may not be practical. In such situations, knowledge of the dosimetric impact of the surface curvature provides motivation for avoiding implantation geometries that can lead to either over/underdosing the target, or excess dose to healthy tissue.
定向平面钯-103LDR 装置(CivaSheet)可用于肿瘤部位与健康组织交界处的术中植入。已经研究了将这种高定向装置植入临床治疗中可能遇到的曲面时的剂量学特性。
CivaSheet 设计为定向钯-103 源(CivaDots)阵列。从三名患者的术后计算机断层扫描(CT)扫描中,重建了每个植入 CivaSheet 的形状。为了获得曲率分布的真实估计,计算了每个 CivaDot 位置的平均曲率半径。基于已发表的几何形状和材料规格,设计了单个 CivaDot 的蒙特卡罗模拟(FLUKA)。CivaDot 的径向剂量函数模拟和二维各向异性函数模拟均通过与胶片测量进行比较进行了验证,并与已发表的蒙特卡罗数据进行了基准测试。还计算了水中 CivaDot 源的剂量率常数Λ=0.587(19)cGy/h/U。由于知道了每个源附近的剂量分布,因此可以计算出不同曲率和取向的 CivaSheet 周围任何点的剂量。
在所有三个患者植入物中,局部曲率半径主要在 2 到 8 厘米之间。在半径为 2 厘米的向内弯曲 CivaSheet 植入物的未屏蔽侧,0.5 厘米深度处的计算剂量超过规定剂量约 20%,而在屏蔽侧,剂量增加了一倍,从而降低了原始设计的屏蔽效率。在向外弯曲植入物的未屏蔽侧,0.5 厘米深度处的剂量减少了约 20%。
当可以从预规划 CT 扫描中估计肿瘤床曲率时,本研究的结果为修改源强度以达到预期临床结果提供了定量指导。然而,在许多术中情况下,基于表面曲率的准确预规划可能不切实际。在这种情况下,了解表面曲率的剂量学影响为避免导致靶区剂量过高/过低或健康组织过量剂量的植入几何形状提供了动力。